COMMUNIQUÉS West-GlobeNewswire
-
DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq
30/07/2026 -
FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026
30/07/2026 -
InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing
30/07/2026 -
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
30/07/2026 -
DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
30/07/2026 -
Correction: Inventiva Announces Preliminary Financial Results for the First Half of 2026¹
30/07/2026 -
Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma
31/07/2026 -
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026
30/07/2026 -
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
31/07/2026 -
Voting Rights and Shares Capital of the Company
30/07/2026 -
Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda
30/07/2026 -
Cellectis publiera ses résultats financiers du deuxième trimestre jeudi 6 août 2026
30/07/2026 -
Laguna Treatment Center Now Offers Virtual Outpatient Services for those Struggling with Addiction
31/07/2026 -
Mdxhealth to Release Second Quarter 2026 Financial Results on August 13
30/07/2026 -
Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod
30/07/2026 -
Cellectis to Report Second Quarter Financial Results on August 6, 2026
30/07/2026 -
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
30/07/2026 -
CooperCompanies Announces Release Date for Third Quarter 2026
30/07/2026 -
Telix H1 2026 Results: Investor Webcast Notification
31/07/2026
Pages